Richard Barker (life sciences and healthcare leader)

Unite Us Celebrates a Year of Nationwide Impact, Improving Cross-Sector Collaboration and Quality of Life for 18.7M Americans To Date

Retrieved on: 
Thursday, January 12, 2023

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Unite Us, the nation's leading software company enabling cross-sector collaboration announced it has impacted and improved the health and well-being of more than 18.7 million people since the 2013 launch of its software, bringing together healthcare, government, nonprofit, and private-sector partners to address social determinants of health (SDoH).

Key Points: 
  • "We've seen an increased need for social support across the country this year," said Dan Brillman, Co-Founder and CEO at Unite Us.
  • "I'm extremely proud of our team for rising to the occasion, readily creating capacity and building efficiency for our partners.
  • Most notably, the Unite Us Platform has driven year-over-year improvement in:
    Partnering with maternal and child well-being through programs like First 1,000 Days Suncoast.
  • To learn more about Unite Us' SDoH software and social care infrastructure, visit www.UniteUs.com .

ZyVersa Therapeutics Appoints Three New Board Members

Retrieved on: 
Thursday, January 5, 2023

ZyVersa appoints three new independent board members, bringing the total board membership to seven.

Key Points: 
  • ZyVersa appoints three new independent board members, bringing the total board membership to seven.
  • The existing board of ZyVersa appointed the following new board members: Gregory G. Freitag, J.D., CPA; Katrin Rupalla, PhD; and James Sapirstein.
  • "We are delighted to welcome our three new board members at this important time in ZyVersa's evolution," stated Stephen C. Glover.
  • Dr. Rupalla is also the Chair of the board of AMBRX, and a board member of the non-profit Cancer Drug Development Forum.

Tampa General Hospital Senior Director of Data Analytics is Nationally Recognized as a Rising Star in Health Care

Retrieved on: 
Thursday, December 22, 2022

TAMPA, Fla., Dec. 22, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) Senior Director of Data Analytics, Etter Hoang, is being nationally recognized for his groundbreaking work to advance the application of health care data analytics. Becker's Hospital Review, a digital and print publication, has named Hoang to its 2022 list of Rising Stars: 104 Healthcare Leaders to Know.

Key Points: 
  • Becker's Hospital Review names Etter Hoang to its Rising Stars: 104 Healthcare Leaders to Know list for his innovative approach to data analytics and health care administration.
  • TAMPA, Fla., Dec. 22, 2022 /PRNewswire/ -- Tampa General Hospital (TGH) Senior Director of Data Analytics, Etter Hoang, is being nationally recognized for his groundbreaking work to advance the application of health care data analytics.
  • Hoang oversees the Tampa General Enterprise Analytics team as well as leads the development of enterprise vision and strategy for analytics as part of Tampa General's Data Council and Executive Analytics Steering Committee.
  • Tampa General Hospital has been designated as a model of excellence by the 2022 Fortune/Merative 100 Top Hospitals list.

IR-Med Announces Dr. David Dalton as Advisory Board member

Retrieved on: 
Wednesday, November 16, 2022

Rosh Pinna, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) -- "IR-MED” or the "Company") (OTCQB:IRME), an innovative medical device company that develops non-invasive, real-time detection devices that utilize Infrared Light Spectroscopy (IR) and Artificial Intelligence (AI) for use by healthcare professionals, welcomes Dr. David Dalton to the Company's Advisory Board. As part of the Advisory Board, Dr. Dalton will offer insights on the company's PressureSafe device for the early detection of pressure injuries (PI). Dr. Dalton will support IR-Med with analyzing the benefits of the PressureSafe device for Hispanic and African American populations in the United States, two groups that, according to a study, published on Pubmed.gov, suffer from pressure wounds almost twice as much as the Caucasian population due to late discovery.

Key Points: 
  • As part of the Advisory Board, Dr. Dalton will offer insights on the company's PressureSafe device for the early detection of pressure injuries (PI).
  • Dr. David Dalton is a hall of fame CEO, entrepreneur, pharmaceutical executive, and founder of over 40 companies.
  • He is currently Board Director and Executive Chairman of six companies and leads the chain drug industry as the first black executive.
  • His accolades include being an inductee in three halls of fame and a recipient of the Senatorial Medal of Freedom.

ECRI Names Monument Health Winner of 2022 Safety Excellence Award

Retrieved on: 
Monday, November 7, 2022

PLYMOUTH MEETING, Pa., Nov. 7, 2022 /PRNewswire/ -- ECRI, the nation's largest nonprofit patient safety organization, names Monument Health of Rapid City, SD, winner of the 2022 Safety Excellence Award. Monument Health is recognized for exceeding organization-wide safety goals of reducing harm and errors by improving culture of safety and event reporting.

Key Points: 
  • Bestowed by the joint ECRI and Institute for Safe Medication Practices PSO, the award lauds the South Dakota health system for improving culture of safety
    PLYMOUTH MEETING, Pa., Nov. 7, 2022 /PRNewswire/ --ECRI, the nation's largest nonprofit patient safety organization, names Monument Health of Rapid City, SD, winner of the 2022 Safety Excellence Award.
  • The Safety Excellence Award recognizes a member of the joint ECRI and the Institute for Safe Medication Practices (ISMP) PSO for outstanding patient safety efforts and initiatives.
  • "We applaud Monument Health for advancing patient safety through increased reporting and other process improvements," says Dheerendra Kommala, MD, chief medical officer, ECRI.
  • The 2022 Safety Excellence Award ceremony took place at the ECRI and the ISMP PSO's Annual Meeting, held virtually on November 2, 2022.

Framework Solutions Launches Medical Affairs Division with Appointment of Key Executive

Retrieved on: 
Thursday, October 6, 2022

D., as Executive Vice President, Medical Affairs, effectiveOctober 3, 2022.

Key Points: 
  • D., as Executive Vice President, Medical Affairs, effectiveOctober 3, 2022.
  • "Norm is an accomplished Medical Affairs leader with a proven track record of success.
  • Dr. Enriquez is an experienced Medical Affairs biotech executive, clinician, and entrepreneur with a proven track record of success in building and leading high performing medical teams.
  • Dr. Enriquez' extensive past experience included tenures at CytomX Therapeutics (Vice President, Medical Affairs), The Medical Affairs Company (Principal, TMAC Advisors), Amgen (Executive Director, Global Medical Development),and Sanofi / Aventis (Director, Field-based Medical).

Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care

Retrieved on: 
Monday, September 19, 2022

SAN DIEGO, Sept. 19, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will convene a panel titled "Clinical Genomics Is Now. Are You Ready?" at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and chemical engineer Frances Arnold of the California Institute of Technology. The September 28 roundtable will focus on genomics' role in transforming human health and the next steps in bridging research and clinical genomics.

Key Points: 
  • at its inaugural Illumina Genomics Forum (IGF), moderated by Nobel laureate and chemical engineer Frances Arnold of the California Institute of Technology.
  • The September 28 roundtable will focus on genomics' role in transforming human health and the next steps in bridging research and clinical genomics.
  • "We are honored to have Nobel laureate Frances Arnold join our remarkable lineup of genomics and health care leaders to guide this important discussion demonstrating the spectrum of clinical utility now and the exciting road ahead," said Kathryne Reeves, chief marketing officer of Illumina.
  • To learn more,visit illumina.com and connect with us on Twitter , Facebook , LinkedIn , Instagram , and YouTube .

Head of Global Healthcare Logistics Company CRYOPDP Wins Business Worldwide Magazine CEO Award

Retrieved on: 
Wednesday, September 7, 2022

Unlike many other business awards, which focus on companies as a whole, here the emphasis is on the people who lead them.

Key Points: 
  • Unlike many other business awards, which focus on companies as a whole, here the emphasis is on the people who lead them.
  • Cedric Picaud was the outright winner in his category, being named 'Most Innovative CEO in the Healthcare Logistics Industry'.
  • CRYOPDP is a global expert in temperature-controlled logistics and supply chain solutions for clients in the Life Science and Healthcare field.
  • To find out more about CRYOPDP's trailblazing work, visit https://www.cryopdp.com/
    Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world.

Head of Global Healthcare Logistics Company CRYOPDP Wins Business Worldwide Magazine CEO Award

Retrieved on: 
Wednesday, September 7, 2022

Unlike many other business awards, which focus on companies as a whole, here the emphasis is on the people who lead them.

Key Points: 
  • Unlike many other business awards, which focus on companies as a whole, here the emphasis is on the people who lead them.
  • Cedric Picaud was the outright winner in his category, being named 'Most Innovative CEO in the Healthcare Logistics Industry'.
  • CRYOPDP is a global expert in temperature-controlled logistics and supply chain solutions for clients in the Life Science and Healthcare field.
  • To find out more about CRYOPDP's trailblazing work, visit https://www.cryopdp.com/
    Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world.

Dr. Mark Leondires, Medical Director and Partner in Reproductive Endocrinology at Illume Fertility Receives Crain's Notable Healthcare Leaders Award

Retrieved on: 
Tuesday, September 6, 2022

NORWALK, Conn., Sept. 6, 2022 /PRNewswire-PRWeb/ -- Illume Fertility (formerly RMA of Connecticut), a leading modern fertility practice whose exceptional quality and care helps couples and individuals grow their families, has announced that Medical Director and Partner in Reproductive Endocrinology, Dr. Mark Leondires, has received the Crain's Notable Healthcare Leaders Award.

Key Points: 
  • Those making this Notable Healthcare Leaders list come from hospitals, government agencies, tech startups and related fields.
  • "We are grateful to have such a quick-thinking, compassionate, dedicated leader in Dr. Leondires," says Illume Fertility's CEO, Robin Mangieri.
  • For the last five years, Illume Fertility has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign.
  • The Fertility Partners team is composed of best-in-field fertility experts and business leaders working collaboratively with partner practices to optimize the fertility clinic experience, exceed patients' expectations and continue to advance reproductive science.